Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1967 1
1969 1
1971 1
1973 1
1974 3
1975 1
1977 1
1978 8
1979 2
1982 2
1983 4
1984 5
1985 5
1986 1
1987 1
1988 7
1989 7
1990 8
1991 6
1992 4
1993 8
1994 5
1995 6
1996 11
1997 6
1998 10
1999 11
2000 14
2001 10
2002 26
2003 20
2004 13
2005 16
2006 21
2007 19
2008 27
2009 36
2010 37
2011 35
2012 55
2013 54
2014 39
2015 63
2016 57
2017 49
2018 52
2019 54
2020 44
2021 51
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

825 results
Results by year
Filters applied: . Clear all
Page 1
Current Clinical Applications of In Vivo Gene Therapy with AAVs.
Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, Boye SL, Boye SE, George LA, Salabarria S, Corti M, Byrne BJ, Tremblay JP. Mendell JR, et al. Among authors: byrne bj. Mol Ther. 2021 Feb 3;29(2):464-488. doi: 10.1016/j.ymthe.2020.12.007. Epub 2020 Dec 10. Mol Ther. 2021. PMID: 33309881 Free article. Review.
Advancements in AAV-mediated Gene Therapy for Pompe Disease.
Salabarria SM, Nair J, Clement N, Smith BK, Raben N, Fuller DD, Byrne BJ, Corti M. Salabarria SM, et al. Among authors: byrne bj. J Neuromuscul Dis. 2020;7(1):15-31. doi: 10.3233/JND-190426. J Neuromuscul Dis. 2020. PMID: 31796685 Free PMC article. Review.
Pompe disease diagnosis and management guideline.
Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, Crowley JF, Downs S, Howell RR, Kravitz RM, Mackey J, Marsden D, Martins AM, Millington DS, Nicolino M, O'Grady G, Patterson MC, Rapoport DM, Slonim A, Spencer CT, Tifft CJ, Watson MS. Kishnani PS, et al. Among authors: byrne bj. Genet Med. 2006 May;8(5):267-88. doi: 10.1097/01.gim.0000218152.87434.f3. Genet Med. 2006. PMID: 16702877 Free PMC article. No abstract available.
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study.
Pena LDM, Barohn RJ, Byrne BJ, Desnuelle C, Goker-Alpan O, Ladha S, Laforêt P, Mengel KE, Pestronk A, Pouget J, Schoser B, Straub V, Trivedi J, Van Damme P, Vissing J, Young P, Kacena K, Shafi R, Thurberg BL, Culm-Merdek K, van der Ploeg AT; NEO1 Investigator Group. Pena LDM, et al. Among authors: byrne bj. Neuromuscul Disord. 2019 Mar;29(3):167-186. doi: 10.1016/j.nmd.2018.12.004. Epub 2018 Dec 17. Neuromuscul Disord. 2019. PMID: 30770310 Free article. Clinical Trial.
Considerations for Systemic Use of Gene Therapy.
Byrne BJ, Corti M, Muntoni F. Byrne BJ, et al. Mol Ther. 2021 Feb 3;29(2):422-423. doi: 10.1016/j.ymthe.2021.01.016. Epub 2021 Jan 14. Mol Ther. 2021. PMID: 33485465 Review. No abstract available.
Neonatal outreach simulation.
Byrne BJ, Manhas D. Byrne BJ, et al. Semin Perinatol. 2016 Nov;40(7):480-488. doi: 10.1053/j.semperi.2016.08.009. Epub 2016 Sep 28. Semin Perinatol. 2016. PMID: 27692476 Review.
Transporter oligomerisation: roles in structure and function.
Cecchetti C, Pyle E, Byrne B. Cecchetti C, et al. Among authors: byrne b. Biochem Soc Trans. 2019 Feb 28;47(1):433-440. doi: 10.1042/BST20180316. Epub 2018 Dec 21. Biochem Soc Trans. 2019. PMID: 30578344 Free PMC article. Review.
Transporter oligomerization: form and function.
Alguel Y, Cameron AD, Diallinas G, Byrne B. Alguel Y, et al. Among authors: byrne b. Biochem Soc Trans. 2016 Dec 15;44(6):1737-1744. doi: 10.1042/BST20160217. Biochem Soc Trans. 2016. PMID: 27913684 Free PMC article. Review.
825 results